Voting results of 08th AGM of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs filed the voting results of its 8th Annual General Meeting held on September 30, 2025, along with the Scrutinizer's Report. All 7 resolutions were approved, including adoption of audited financial statements for FY25, re-appointment of Mr. Arjan Lalchandani as Director, appointment of secretarial auditors for 5 years (FY26-FY30), re-appointment of Mr. Mohit Lalchandani as Whole Time Director for 5 years, appointment of Mr. Mohan Lal Gandhi as Independent Director for 5 years, increase in authorized share capital, and alteration of the Capital clause of the MOA. Out of 209 shareholders on record date, only 10 attended in person (3 promoters and 7 public). Of the 43.33 lakh total shares, 18.42 lakh votes (42.51%) were polled, with 94.57% voting in favor and 5.43% against across resolutions.
The approval of the authorized share capital increase and MOA amendment signals the company's preparedness for potential future fundraising or stock issuance. All resolutions passed with strong majority (over 86% in favor), indicating stable promoter and shareholder support, though overall voting turnout at ~42.5% was modest.